Randomized trial · people

NAD+ rose with nicotinamide riboside in a 6-week crossover trial

Checked against the paper Randomized trialPublished by PepVault

The takeaway

This trial shows that ongoing use of an NAD+ precursor raised NAD+ metabolism in healthy middle-aged and older adults and was well tolerated for 6 weeks. Any heart or blood vessel benefit is still unproven.

Kind
Randomized trial
Studied in
People
Published
2018
Journal
Nat Commun

What they tested

The team tested whether ongoing supplementation with nicotinamide riboside (NR), a vitamin the body uses to make NAD+, is well tolerated and raises NAD+ in healthy middle-aged and older people.

How the study was done

A randomized, double-blind, placebo-controlled crossover trial in healthy middle-aged and older adults. Each person had 6 weeks of NR and 6 weeks of placebo (an inactive look-alike), in random order, without knowing which was which.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

People tolerated NR well across the 6-week supplementation period. NR boosted NAD+ metabolism. The researchers also took an early look at body function, and they singled out blood pressure and arterial stiffness (how rigid the artery walls are) as areas for future trials to study further.

What it doesn’t show

Each treatment period lasted only 6 weeks, and everyone was healthy, so the trial does not show long-term effects or effects in people with disease. The blood pressure and arterial stiffness results were only a first look, and this trial does not show that NR lowers either.

The paper

Martens et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018.

The compound

More studies on NAD+

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo